Children's Health Quality Reporting
At Hackensack Meridian Children’s Health, our passion is to ensure a safe and high-quality environment for all. We are on our journey to become a high reliability organization.
A high reliability organization delivers excellence in quality and safety always. Our journey includes process improvement, team member training, and partnering with patients and their families to shape our future behaviors and culture. To understand how our efforts are working, we closely monitor outcomes of the care we provide. The links below share some of the quality and safety work being done at Hackensack Meridian Children’s Health.
Central Line-Associated Bloodstream Infections (CLABSI)
Why do we want to prevent CLABSIs?
- A central line (also known as a central venous catheter) is a catheter or tube that doctors may place in a large vein to deliver necessary treatment. Central lines can remain in place for a long time. They are commonly used in intensive care units and in children with conditions that need prolonged treatment.
- A Central Line-Associated Bloodstream Infection (CLABSI) happens when germs (usually bacteria) enter the bloodstream through a central line. This can result in a serious infection.
- By following strict protocols every time the central line is used, Hackensack Meridian Children’s Health works very hard to prevent infection.
How do we measure CLABSIs?
- Hackensack Meridian Children’s Health follows the standards set by the National Healthcare Safety Network to measure CLABSIs.
- The CLABSI rate is the number of infections per 1,000 central line days. Every day a child has a central line in place counts as one central line day.
What are we doing to prevent CLABSIs?
- We strictly follow high reliability practices in our continuous effort to prevent CLABSIs.
- We focus on best practices and follow standardized protocols which have been proven to lower infection risk.
- We communicate effectively by auditing our practices, regularly reviewing data, and sharing data with patients, team members, and other hospitals.
- We speak up for safety, thoroughly reviewing each CLABSI event to identify improvement opportunities.
- We partner with colleagues and families, by actively participating in Solutions for Patient Safety, a national improvement collaborative aimed at eliminating all patient harm.
Our Results
Unplanned Extubation (UE)
Why do we want to prevent UEs?
- When children are sick, sometimes they need a breathing tube (called an endotracheal tube) and a special machine (called a ventilator) to help them breathe.
- An unplanned extubation (UE) happens when the endotracheal tube is removed or displaced unintentionally.
- Sometimes, this is because the child accidentally pulls the tube out or the tube is moved when the child is being cared for.
- We want to prevent UEs to keep our patients comfortable and safe.
How do we measure UEs?
- The UE rate is the number of UEs per 100 ventilator days. Every day a child needs a ventilator counts as one ventilator day.
What are we doing to prevent UEs?
- We strictly follow high reliability practices in our continuous effort to prevent UEs. We focus on best practices and follow standardized protocols which have been shown to lower UE risk.
- We communicate effectively by auditing our practices, regularly reviewing data, and sharing data with patients, team members, and other hospitals.
- We speak up for safety, thoroughly reviewing each UE event to identify improvement opportunities.
- We partner with colleagues and families, working together to take extra care when children need to be moved or cared for, and actively participate in Solutions for Patient Safety, a national improvement collaborative aimed at eliminating all patient harm.
Our Results
Reducing Albuterol in Bronchiolitis
Why do we want to reduce albuterol use in bronchiolitis?
- Bronchiolitis is a lung infection caused by a virus. It can lead to fever, mucus, cough, and difficulty breathing.
- Bronchiolitis is one of the most common reasons young children need to be in the hospital.
- Wheezing frequently occurs in children with bronchiolitis. In the past, children were often treated with albuterol - a medication to improve wheezing.
- However, many research studies have shown that albuterol is not an effective treatment in bronchiolitis. In fact, the American Academy of Pediatrics recommends against giving albuterol in bronchiolitis to avoid side effects and reduce unnecessary treatment.
How do we measure this?
- The rate of albuterol use is the number of children admitted to the hospital with bronchiolitis who receive albuterol divided by the number of children admitted to the hospital with bronchiolitis. The metric is reported as a percent.
How are we doing?
- Hackensack Meridian Children’s Health has a multidisciplinary group dedicated to ensuring our patients receive high quality and safe care.
- We trained our team members, followed evidence-based care protocols, and optimized our electronic health record. We reduced unnecessary albuterol use from 25.5% to 9.2% for children admitted with bronchiolitis.
Our Results
